Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

International Journal of Clinical and Experimental Medicine

Volumn 5, Issue 3, 2012, Pages 208-220

  Booth, Norman E ^a   Myhill, Sarah ^b   McLaren Howard, John ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Llangunllo Powys   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Adenosine triphosphate (ATP); Cell free DNA; Cellular energetic; Chronic fatigue syndrome; Exercise; Glycolysis; Mitochondria; Myalgic encephalomyelitis; Oxidative phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL ENERGY; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; HUMAN; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; NEUROTRANSMISSION; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY;

EID: 84864294525     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am J Med 1959; 26: 569-595.
2. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles ACP, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo- Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML and Stevens S. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011; 270: 327-338.
3. Myhill S, Booth NE and McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med 2009; 2: 1-16.
4. Bell DS. The Doctor's Guide to Chronic Fatigue Syndrome. New York: Da Capo Press, 1994.
5. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-959.
6. Henchcliffe C and Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neuro 2008; 4: 600-609.
7. Rossignol DA and Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 2012; 17: 290-314.
8. Nicolson GL. Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J Cell Biochem 2007; 100: 1352-1369.
9. Golomb BA. Oxidative Stress and Mitochondrial Injury in Chronic Multisystem Conditions: From Gulf War Illness to Autism Spectrum Disorder. Nature Precedings 2012. Available from Nature Precedings http://hdl.handle.net/10101/npre.2012.6847.1
10. Barrientos A. In vivo and in organello assessment of OXPHOS activities. Methods 2002; 26: 307-316.
11. Brand MD and Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J 2011; 435: 297-312.
12. Lanza IR and Nair KS. Chapter 20: Functional Assessment of Isolated Mitochondria in Vitro. In: William SA, Anne NM, editors. Methods in Enzymology. Academic Press 2009; pp: 349-372.
13. Klingenberg M. The ADP and ATP transport in mitochondria and its carrier. Biochim Biophys Acta 2008; 1778: 1978-2021.
14. Pieczenik SR and Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 2007; 83: 84-92.
15. Vermeulen R, Kurk R, Visser F, Sluiter W and Scholte H. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J Transl Med 2010; 8: 93.
16. Smits B, van den Heuvel L, Knoop H, Küsters B, Janssen A, Borm G, Bleijenberg G, Rodenburg R and van Engelen B. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion 2011; 11: 735-738.
17. Savabi F. Interaction of creatine kinase and adenylate kinase systems in muscle cells. Mol Cell Biochem 1994; 133: 145-152.
18. Dzeja PP and Terzic A. Phosphotransfer networks and cellular energetics. J Exp Biol 2003; 206: 2039-2047.
19. Koolman J and Roehm K-H. Color Atlas of Biochemistry. Stuttgart - New York: Thieme 2005; pp: 336-337.
20. VanNess JM, Stevens SR, Bateman L, Stiles TL and Snell CR. Postexertional Malaise in Women with Chronic Fatigue Syndrome. J Womens Health 2010; 19: 239-244.
21. Lane RJM, Barrett MC, Taylor DJ, Kemp GJ and Lodi R. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscul Disord 1998; 8: 204-209.
22. Barnes PR, Taylor DJ, Kemp GJ and Radda GK. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1993; 56: 679-683.
23. Jones DEJ, Hollingsworth KG, Jakovljevic DG, Fattakhova G, Pairman J, Blamire AM, Trenell MI and Newton JL. Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur J Clin Invest 2012; 42: 186-194.
24. Binzoni T, Cooper CE, Wittekind AL, Beneke R, Elwell CE, Van De Ville D and Leung TS. A new method to measure local oxygen consumption in human skeletal muscle during dynamic exercise using near-infrared spectroscopy. Physiol Meas 2010; 31: 1257-1269.
25. Wu T-L, Zhang D, Chia J-H, Tsao K-C, Sun C-F and Wu JT. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 2002; 321: 77-87.
26. Schmidt B, Weickmann S, Witt C and Fleischhacker M. Improved Method for Isolating Cell-Free DNA. Clin Chem 2005; 51: 1561-1563.
27. Khakh BS. Molecular physiology of P2X receptors and ATP signalling at synapses. In: editors. Nature Rev Neurosci 2001; pp: 165-174.
28. Burnstock G. Pathophysiology and therapeutic potential of purinerguc signaling. Pharm Rev 2006; 58: 58-86.
29. Khakh BS and Burnstock G. The Double Life of ATP. Sci Amer 2009; 301: 84-92.
30. Lawn T, Kumar P, Knight B, Sharpe M and White PD. Psychiatric misdiagnoses in patients with chronic fatigue syndrome. J R Soc Med Sh Rep 2010; 1: 1-7.